Friday 6 November 2026 Export JNJ’s income statement to Excel — free account

Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024.

Revenue: +5.86%
EPS: −95.8%
Free cash flow: −21.4%
Total debt: −9.16%

Quarter to September 2026, against a year earlier

275.17 2.85 +1.05%

Follow JNJ

Alert me

Market cap: $655.6B
P/E: 41.3×
Fwd P/E: 40.0×
Dividend yield: 1.94%
F-score: 3/9
Altman Z: 4.78
Beneish M: −2.26
Dividend safety: 78/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	4	6	5
ROE Full definition →		35.03%	26.42%	25.74%	20.02%
ROA Full definition →		14.13%	10.66%	10.67%	8.25%
ROIC Full definition →		20.19%	16.13%	15.51%	11.07%
Return on Tangible Assets Full definition →		108.66%	85.09%	73.92%	64.39%
Average Days of Receivables Full definition →		66.57	67.12	70.99	69.77
Free Cash Flow per Share Full definition →		8.48	7.58	9.44	8.71
Free Cash Flow Full definition →		20,418.00	18,254.00	22,724.00	20,990.00
Capital Expenditures Full definition →		(4,112.00)	(4,616.00)	(4,884.00)	(5,169.00)
Other line items
Cash ROIC Full definition →		14.47%	12.97%	15.88%	15.60%
Accounts Receivable Turnover Full definition →		5.88	5.71	5.31	5.43
Accounts Payable Turnover Full definition →		2.71	3.10	3.36	3.40
Inventory Turnover Full definition →		2.27	2.28	2.20	2.18
Average Days of Payables Full definition →		144.66	123.14	107.11	105.54
Days of Inventory on Hand Full definition →		171.20	171.68	175.88	174.19
Tax Rate Full definition →		(0.18)	(0.16)	(0.17)	(0.09)
Research and Development Expense of Revenue Full definition →		15.57%	15.53%	15.42%	16.19%
Selling, General and Administrative Expense of Revenue Full definition →		25.14%	25.53%	25.67%	25.67%
Share Based Compensation of Revenue Full definition →		1.44%	1.42%	1.44%	1.43%
Interest Coverage Full definition →		35.64	25.92	26.80	19.91
Operating CF/Net income Full definition →		0.92	1.09	1.31	1.63
Depreciation/Fixed assets Full definition →		0.32	0.33	0.33	0.34
Capex/Depreciation Full definition →		(0.55)	(0.60)	(0.63)	(0.64)
Revenue per Share Full definition →		39.13	40.01	40.68	41.22
Operating CF per Share Full definition →		10.19	9.49	11.47	10.86
Capex per Share Full definition →		(1.71)	(1.92)	(2.03)	(2.15)
Capex to Sales Full definition →		0.04	0.05	0.05	0.05

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly